Rituximab Terminated Phase 1 / 2 Trials for Stage IV Adult Diffuse Large Cell Lymphoma / Stage III Grade 2 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Stage IV Adult Lymphoblastic Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Noncontiguous Stage II Grade 2 Follicular Lymphoma / Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma / Stage III Adult Diffuse Large Cell Lymphoma / Noncontiguous Stage II Mantle Cell Lymphoma / Stage I Grade 1 Follicular Lymphoma / Stage I Grade 2 Follicular Lymphoma / Contiguous Stage II Mantle Cell Lymphoma / Stage III Adult Burkitt Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Stage IV Adult Hodgkin Lymphoma / Stage III Mantle Cell Lymphoma / Splenic Marginal Zone Lymphoma / Stage IV Marginal Zone Lymphoma / B-Cell Chronic Lymphocytic Leukemia / Stage I Adult Hodgkin Lymphoma / Stage IV Grade 1 Follicular Lymphoma / Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma / Stage I Chronic Lymphocytic Leukemia / Waldenström's Macroglobulinemia (WM) / Contiguous Stage II Adult Lymphoblastic Lymphoma / Contiguous Stage II Adult Diffuse Large Cell Lymphoma / Stage I Adult Diffuse Large Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Recurrent Adult Burkitt Lymphoma / Stage III Chronic Lymphocytic Leukemia / Stage I Adult Burkitt Lymphoma / Stage II Chronic Lymphocytic Leukemia / Stage I Adult Lymphoblastic Lymphoma / Stage IV Chronic Lymphocytic Leukemia / Stage IV Grade 2 Follicular Lymphoma / Stage II Small Lymphocytic Lymphoma / Stage III Adult Lymphoblastic Lymphoma / Contiguous Stage II Grade 1 Follicular Lymphoma / Stage IV Adult Burkitt Lymphoma / Stage II Adult Hodgkin Lymphoma / Recurrent Small Lymphocytic Lymphoma / Contiguous Stage II Grade 2 Follicular Lymphoma / Noncontiguous Stage II Grade 1 Follicular Lymphoma / Stage III Marginal Zone Lymphoma / Noncontiguous Stage II Adult Burkitt Lymphoma / Stage I Small Lymphocytic Lymphoma / Extranodal Marginal Zone B-cell Lymphoma / Stage II Marginal Zone Lymphoma / Stage III Small Lymphocytic Lymphoma / Stage III Adult Hodgkin Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Stage III Grade 1 Follicular Lymphoma / Stage IV Small Lymphocytic Lymphoma / Nodal marginal zone B-cell lymphomas / Stage IV Mantle Cell Lymphoma / Contiguous Stage II Adult Burkitt Lymphoma / Noncontiguous Stage II Adult Lymphoblastic Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01078974Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia